Subcutaneous hematomas from prophylactic heparin use

Abhilash Koratala1, Deepti Bhattacharya1

  • 1Division of Nephrology, Hypertension and Renal Transplantation University of Florida Gainesville Florida.

Clinical Case Reports
|January 30, 2018
PubMed

Heparin is an anticoagulant, which is frequently used in hospitalized patients for prophylaxis of deep vein thrombosis (DVT). Subcutaneous administration of heparin may lead to complications such as bruising, hematoma, and pain at the injection site. Hematomas can develop without visible bruising, as in our case.